Research In Brief
This article was originally published in The Gray Sheet
Executive Summary
St Jude launches post-market study of its renal denervation system. More research news
You may also be interested in...
St. Jude Plans Trial To Study Renal Denervation Outcomes
Landmark trial will evaluate whether reductions in blood pressure caused by renal denervation translate to clinical improvements in patients with hard-to-treat hypertension.
St. Jude Plans Trial To Study Renal Denervation Outcomes
Landmark trial will evaluate if reductions in blood pressure caused by renal denervation translate to clinical improvements in patients with hard-to-treat hypertension.
New Products In Brief
Recent approvals and launches include Cook’s Zilver PTX drug-eluting stent for peripheral arterial disease, Medtronic’s Valiant Captivia stent graft system and Cordis’ S.M.A.R.T. Control vascular stent.